| The Pharmacokinetics (PK), Safety, Tolerability of SR750 (Formulation F1) in Healthy Volunteers (NCT06932536) | Shanghai SIMR Biotechnology Co., Ltd. | 2025-04-28 |
| Efficacy and Safety of SR1375 in Adult Patients With CAP (NCT06577558) | Shanghai SIMR Biotechnology Co., Ltd. | 2024-09-10 |
| The Pharmacokinetics (PK), Safety, Tolerability of SR750 in Healthy Volunteers (NCT05753033) | Shanghai SIMR Biotechnology Co., Ltd. | 2023-02-28 |
| The Pharmacokinetics (PK), Pharmacodynamics(PD), Safety, Tolerability of SR1375 in Healthy Volunteers (NCT05421923) | Shanghai SIMR Biotechnology Co., Ltd. | 2022-06-24 |
| To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN) (NCT05357677) | Shanghai SIMR Biotechnology Co., Ltd. | 2022-05-13 |
| The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers (NCT05083468) | Shanghai SIMR Biotechnology Co., Ltd. | 2021-10-29 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SR1375 (NCT05026008) | Shanghai SIMR Biotechnology Co., Ltd. | 2021-09-30 |
| The Pharmacokinetics (PK), Safety, Tolerability of SR419 in Healthy Volunteers (NCT05012761) | Shanghai SIMR Biotechnology Co., Ltd. | 2021-08-24 |
| A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 (NCT04494815) | Shanghai SIMR Biotechnology Co., Ltd. | 2020-09-18 |
| The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers (NCT04021563) | Shanghai SIMR Biotechnology Co., Ltd. | 2019-07-26 |